AI MARKET SCANNING

Emergent BioSolutions Inc

AVG HISTORICAL GAP -3.94%
MAX GAP RECORD -35.50%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $EBS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
-21.09%
Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE)
+9.23%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
-26.13%
Oct 29, 2025 Earnings Release 2025-10-29 (AFTER CLOSE)
+15.53%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+8.46%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+14.56%
Mar 03, 2025 Earnings Release 2025-03-03 (AFTER CLOSE)
-18.59%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
+24.24%

VOLATILITY & GAP BIAS

AVG GAP MOVE 14.0%
Bullish Gaps (6)
Bearish Gaps (9)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $EBS

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-21 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 3053m +5.92%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗